ref_name,rx_name,iso_name,section,assay_name,potency_type,potency,cumulative_count,potency_upper_limit,potency_lower_limit,potency_unit,date_added
Fenwick21,P5C3,Wuhan-Hu-1,Figure 2B,Pseudovirus (lentivirus),IC50,4,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,P5C3,S:614G,Figure 2B,Pseudovirus (lentivirus),IC50,14,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,P5C3,S:222V,Figure 2B,Pseudovirus (lentivirus),IC50,3,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,P5C3,S:439K,Figure 2B,Pseudovirus (lentivirus),IC50,14,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,P5C3,S:477N,Figure 2B,Pseudovirus (lentivirus),IC50,35,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,P5C3,S:493K,Figure 2B,Pseudovirus (lentivirus),IC50,10,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,P5C3,S:494P,Figure 2B,Pseudovirus (lentivirus),IC50,6,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,P5C3,S:484K+501Y,Figure 2B,Pseudovirus (lentivirus),IC50,4,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,P5C3,S:417N+484K+501Y,Figure 2B,Pseudovirus (lentivirus),IC50,13,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,P5C3,Wuhan-Hu-1,Figure 2B,Pseudovirus (lentivirus),IC80,21,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,P5C3,S:614G,Figure 2B,Pseudovirus (lentivirus),IC80,42,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,P5C3,S:222V,Figure 2B,Pseudovirus (lentivirus),IC80,21,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,P5C3,S:439K,Figure 2B,Pseudovirus (lentivirus),IC80,29,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,P5C3,S:477N,Figure 2B,Pseudovirus (lentivirus),IC80,80,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,P5C3,S:493K,Figure 2B,Pseudovirus (lentivirus),IC80,34,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,P5C3,S:494P,Figure 2B,Pseudovirus (lentivirus),IC80,25,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,P5C3,S:484K+501Y,Figure 2B,Pseudovirus (lentivirus),IC80,21,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,P5C3,S:417N+484K+501Y,Figure 2B,Pseudovirus (lentivirus),IC80,29,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,Wuhan-Hu-1,Figure 2B,Pseudovirus (lentivirus),IC50,14,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,S:614G,Figure 2B,Pseudovirus (lentivirus),IC50,37,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,S:222V,Figure 2B,Pseudovirus (lentivirus),IC50,15,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,S:439K,Figure 2B,Pseudovirus (lentivirus),IC50,37,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,S:477N,Figure 2B,Pseudovirus (lentivirus),IC50,48,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,S:493K,Figure 2B,Pseudovirus (lentivirus),IC50,33,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,S:494P,Figure 2B,Pseudovirus (lentivirus),IC50,28,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,S:484K+501Y,Figure 2B,Pseudovirus (lentivirus),IC50,84,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,S:417N+484K+501Y,Figure 2B,Pseudovirus (lentivirus),IC50,925,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,Wuhan-Hu-1,Figure 2B,Pseudovirus (lentivirus),IC80,47,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,S:614G,Figure 2B,Pseudovirus (lentivirus),IC80,143,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,S:222V,Figure 2B,Pseudovirus (lentivirus),IC80,57,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,S:439K,Figure 2B,Pseudovirus (lentivirus),IC80,86,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,S:477N,Figure 2B,Pseudovirus (lentivirus),IC80,144,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,S:493K,Figure 2B,Pseudovirus (lentivirus),IC80,108,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,S:494P,Figure 2B,Pseudovirus (lentivirus),IC80,98,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,S:484K+501Y,Figure 2B,Pseudovirus (lentivirus),IC80,325,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,S:417N+484K+501Y,Figure 2B,Pseudovirus (lentivirus),IC80,5720,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,Wuhan-Hu-1,Figure 2B,Pseudovirus (lentivirus),IC50,25,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,S:614G,Figure 2B,Pseudovirus (lentivirus),IC50,41,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,S:222V,Figure 2B,Pseudovirus (lentivirus),IC50,16,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,S:439K,Figure 2B,Pseudovirus (lentivirus),IC50,697,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,S:477N,Figure 2B,Pseudovirus (lentivirus),IC50,45,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,S:493K,Figure 2B,Pseudovirus (lentivirus),IC50,37,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,S:494P,Figure 2B,Pseudovirus (lentivirus),IC50,43,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,S:484K+501Y,Figure 2B,Pseudovirus (lentivirus),IC50,39,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,S:417N+484K+501Y,Figure 2B,Pseudovirus (lentivirus),IC50,33,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,Wuhan-Hu-1,Figure 2B,Pseudovirus (lentivirus),IC80,134,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,S:614G,Figure 2B,Pseudovirus (lentivirus),IC80,233,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,S:222V,Figure 2B,Pseudovirus (lentivirus),IC80,70,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,S:439K,Figure 2B,Pseudovirus (lentivirus),IC80,3730,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,S:477N,Figure 2B,Pseudovirus (lentivirus),IC80,140,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,S:493K,Figure 2B,Pseudovirus (lentivirus),IC80,187,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,S:494P,Figure 2B,Pseudovirus (lentivirus),IC80,245,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,S:484K+501Y,Figure 2B,Pseudovirus (lentivirus),IC80,254,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,S:417N+484K+501Y,Figure 2B,Pseudovirus (lentivirus),IC80,210,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,P5C3-LS,Wuhan-Hu-1,Figure 3B,SARS-CoV-2 recombinant,IC50,5,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,P5C3-LS,S:614G,Figure 3B,SARS-CoV-2 recombinant,IC50,11,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,P5C3-LS,S:69del+70del+144del+501Y+570D+614G+681H+716I+982A+1118H,Figure 3B,SARS-CoV-2 recombinant,IC50,5,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,P5C3-LS,S:18F+80A+215G+242del+243del+244del+246I+417N+484K+501Y+614G+701V,Figure 3B,SARS-CoV-2 recombinant,IC50,8,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,P5C3-LS,S:5F+69del+70del+453F+614G+751Y+1250F,Figure 3B,SARS-CoV-2 recombinant,IC50,3,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,P5C3-LS,Wuhan-Hu-1,Figure 3B,SARS-CoV-2 recombinant,IC80,11,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,P5C3-LS,S:614G,Figure 3B,SARS-CoV-2 recombinant,IC80,22,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,P5C3-LS,S:69del+70del+144del+501Y+570D+614G+681H+716I+982A+1118H,Figure 3B,SARS-CoV-2 recombinant,IC80,11,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,P5C3-LS,S:18F+80A+215G+242del+243del+244del+246I+417N+484K+501Y+614G+701V,Figure 3B,SARS-CoV-2 recombinant,IC80,14,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,P5C3-LS,S:5F+69del+70del+453F+614G+751Y+1250F,Figure 3B,SARS-CoV-2 recombinant,IC80,8,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,Wuhan-Hu-1,Figure 3B,SARS-CoV-2 recombinant,IC50,48,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,S:614G,Figure 3B,SARS-CoV-2 recombinant,IC50,35,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,S:69del+70del+144del+501Y+570D+614G+681H+716I+982A+1118H,Figure 3B,SARS-CoV-2 recombinant,IC50,8,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,S:18F+80A+215G+242del+243del+244del+246I+417N+484K+501Y+614G+701V,Figure 3B,SARS-CoV-2 recombinant,IC50,3354,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,S:5F+69del+70del+453F+614G+751Y+1250F,Figure 3B,SARS-CoV-2 recombinant,IC50,1064,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,Wuhan-Hu-1,Figure 3B,SARS-CoV-2 recombinant,IC80,148,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,S:614G,Figure 3B,SARS-CoV-2 recombinant,IC80,114,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,S:69del+70del+144del+501Y+570D+614G+681H+716I+982A+1118H,Figure 3B,SARS-CoV-2 recombinant,IC80,22,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,S:18F+80A+215G+242del+243del+244del+246I+417N+484K+501Y+614G+701V,Figure 3B,SARS-CoV-2 recombinant,IC80,10000,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10933,S:5F+69del+70del+453F+614G+751Y+1250F,Figure 3B,SARS-CoV-2 recombinant,IC80,8400,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,Wuhan-Hu-1,Figure 3B,SARS-CoV-2 recombinant,IC50,28,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,S:614G,Figure 3B,SARS-CoV-2 recombinant,IC50,24,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,S:69del+70del+144del+501Y+570D+614G+681H+716I+982A+1118H,Figure 3B,SARS-CoV-2 recombinant,IC50,4,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,S:18F+80A+215G+242del+243del+244del+246I+417N+484K+501Y+614G+701V,Figure 3B,SARS-CoV-2 recombinant,IC50,12,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,S:5F+69del+70del+453F+614G+751Y+1250F,Figure 3B,SARS-CoV-2 recombinant,IC50,6,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,Wuhan-Hu-1,Figure 3B,SARS-CoV-2 recombinant,IC80,104,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,S:614G,Figure 3B,SARS-CoV-2 recombinant,IC80,124,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,S:69del+70del+144del+501Y+570D+614G+681H+716I+982A+1118H,Figure 3B,SARS-CoV-2 recombinant,IC80,11,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,S:18F+80A+215G+242del+243del+244del+246I+417N+484K+501Y+614G+701V,Figure 3B,SARS-CoV-2 recombinant,IC80,32,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,REGN10987,S:5F+69del+70del+453F+614G+751Y+1250F,Figure 3B,SARS-CoV-2 recombinant,IC80,21,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,S309,Wuhan-Hu-1,Figure 3B,SARS-CoV-2 recombinant,IC50,147,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,S309,S:614G,Figure 3B,SARS-CoV-2 recombinant,IC50,259,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,S309,S:69del+70del+144del+501Y+570D+614G+681H+716I+982A+1118H,Figure 3B,SARS-CoV-2 recombinant,IC50,299,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,S309,S:18F+80A+215G+242del+243del+244del+246I+417N+484K+501Y+614G+701V,Figure 3B,SARS-CoV-2 recombinant,IC50,365,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,S309,S:5F+69del+70del+453F+614G+751Y+1250F,Figure 3B,SARS-CoV-2 recombinant,IC50,127,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,S309,Wuhan-Hu-1,Figure 3B,SARS-CoV-2 recombinant,IC80,522,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,S309,S:614G,Figure 3B,SARS-CoV-2 recombinant,IC80,622,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,S309,S:69del+70del+144del+501Y+570D+614G+681H+716I+982A+1118H,Figure 3B,SARS-CoV-2 recombinant,IC80,1950,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,S309,S:18F+80A+215G+242del+243del+244del+246I+417N+484K+501Y+614G+701V,Figure 3B,SARS-CoV-2 recombinant,IC80,564,1,10000,0.1,ng/ml,2021-10-07
Fenwick21,S309,S:5F+69del+70del+453F+614G+751Y+1250F,Figure 3B,SARS-CoV-2 recombinant,IC80,454,1,10000,0.1,ng/ml,2021-10-07
